|Bid||67.31 x 800|
|Ask||68.16 x 1300|
|Day's range||63.15 - 72.50|
|52-week range||20.67 - 99.27|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||39.21|
|Earnings date||08 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||98.50|
When you're looking for growth investments, it can pay to bet on innovators that bring a special technology to the table. On that note, InMode (NASDAQ: INMD) is a cosmetic medical-device company that's disrupting its industry by giving people the option to avoid plastic surgery while still delivering surgery-like, aesthetic results. InMode got its start in 2008 and its products today have a handful of key advantages that its competitors don't have.
Intuitive Surgical (NASDAQ: ISRG) InMode (NASDAQ: INMD) are both technology-intensive companies that are aggressive disruptors in their respective healthcare markets, and the similarities don't end there. Whereas Intuitive Surgical makes da Vinci surgical robots used by general surgeons in hospitals, InMode produces advanced beauty treatment equipment that fills a similar role to both laser skin treatments and plastic surgeries. While Intuitive is a behemoth worth $126 billion, InMode's market cap is only $7 billion -- but both businesses have plenty of room to grow.
Strong fundamentals and big money buy signals make these stocks worthy of extra attention.